Key day tomorrow to see if the reversal is in. Otherwise, IMO, the support at $50 will fall and it will test the 200ma at $45ish. That support looks to be very strong and it will take a lot to break through there.
CEO seems to be converting small amounts of his options and selling them. I'm not sure if this is a huge flag, he seems to be selling relatively small blocks (4-20k) and has almost 2.5m left to convert. They expire in 2014 so maybe this is his plan to slowly convert and sell over the next couple years instead of doing it all at once right before they expire? Also, most of the shares seem like they have been exercisable since mid 2008, when the stock was in the high teens. Now it is in the high 50's, so it seems like he has earned his payday.. Just a thought, I don't have much to go on fundamentally besides the form 4s, any other insight on this would be appreciated.
Recent INFA News
- Informatica to Welcome Data and AI Visionaries at Informatica World 2024 • Business Wire • 05/02/2024 01:15:00 PM
- Informatica Reports First Quarter 2024 Financial Results • Business Wire • 05/01/2024 08:05:00 PM
- Informatica Provides Business and Financial Updates • Business Wire • 04/22/2024 01:10:00 PM
- Li Auto Stock Drops 7.3% Amid Tesla Price Cuts, Salesforce Retreats from Informatica Deal, and Other Market Updates • IH Market News • 04/22/2024 12:09:21 PM
- Apple to Invest $250 Million in Singapore Expansion, Oracle Commits $8 Billion to Japan Infrastructure, and More News • IH Market News • 04/18/2024 11:11:52 AM
- Samsung Surpasses Apple in Q1 Smartphone Market; Salesforce in Talks to Acquire Informatica, and More News • IH Market News • 04/15/2024 11:06:48 AM
- Informatica To Report First Quarter 2024 Financial Results on May 1, 2024 • Business Wire • 04/10/2024 08:05:00 PM
- Informatica Expands Partnership with Google Cloud, Launches Extension for Trusted Customer Data Analytics and Enterprise Gen AI Applications • Business Wire • 04/10/2024 01:00:00 PM
- Informatica Launches Saudi Arabia’s First AI-Powered Intelligent Data Management Cloud Platform • Business Wire • 04/02/2024 08:00:00 AM
- Informatica Named a Leader in the 2024 Gartner® Magic Quadrant™ for Data Quality Solutions 16 Consecutive Times • Business Wire • 03/11/2024 04:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/07/2024 09:23:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/07/2024 09:21:45 PM
- Pharmarack Revolutionizes Healthcare Network of India with Informatica’s AI-Powered Data Management Cloud Platform • Business Wire • 03/05/2024 02:00:00 PM
- Informatica Launches Cloud Data Access Management, Industry’s First AI-Powered Solution for Automating Data Access Policy Enforcement at Scale • Business Wire • 02/29/2024 02:45:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 12:30:40 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/22/2024 09:21:03 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/22/2024 09:07:59 PM
- Informatica Named a Leader in the 2024 Gartner® Magic Quadrant™ for iPaaS • Business Wire • 02/22/2024 07:59:00 PM
- Informatica Named a Leader in the 2024 Gartner® Magic Quadrant™ for iPaaS • Business Wire • 02/22/2024 04:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2024 01:14:45 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2024 01:12:01 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2024 01:10:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2024 01:07:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2024 01:03:24 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/15/2024 09:26:09 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM